Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Total assets by reportable segment) (Details)

v3.22.1
Segment Information (Total assets by reportable segment) (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Intangible asset, net $ 30,457 $ 12,552
Tangible assets 377,473 383,951
Total assets 407,930 396,503
Dermatology Products Sales [Member]    
Segment Reporting Information [Line Items]    
Intangible asset, net 30,457 12,552
Tangible assets 90,444 84,732
Total assets 120,901 97,284
Pharmaceutical and Biotechnology Product Development [Member]    
Segment Reporting Information [Line Items]    
Tangible assets 287,029 299,219
Total assets $ 287,029 $ 299,219